Valued at a market cap of $600 million, Aduro is a small-cap Canadian stock that offers massive upside potential in 2025.
Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you ...
Northwestern Engineering’s Zdeněk Bažant and Omar Farha have been named 2025 fellows of the National Academy of Inventors ...
The newly granted U.S. patent, No. 12,492,178, includes claims to the drug substance of EMP-01, and is expected to provide exclusivity through 2043. This patent identifies a highly-crystalline, ...
Opinion: The US Patent and Trademark Office's reexamination of one of Nintendo's patents without a third-party petition sends ...
The U.S. stock market as a whole may be thriving right now, but some stocks just aren't winning investors over. Usually, when ...
This article is the second installment in our three-part series, Artificial Intelligence as Intellectual Property or “AI as IP™”, which explores ...
Product liability and real estate practices are well represented, as the Am Law 50 firm returns to electing a typical number of new partners.
5dOpinion
InnoScience Makes Progress In Patent Dispute, But Growing Competition Remains Bigger Threat
Morgan Stanley, in an October note, projected that InnoScience's revenue would outpace overall GaN market growth, expanding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback